Brian J. Quattrochi, MD, PhD
2020-2021 Fellow, Dermatopathology, Harvard-Mass General Brigham
2017-2020 Resident, Anatomic Pathology, Brigham and Women’s Hospital
2017 MD, T.H. Chan School of Medicine, University of Massachusetts Medical School
2015 PhD, Morningside School of Biomedical Sciences, University of Massachusetts Medical School
2006 BS, Massachusetts Institute of Technology
2020 Anatomic Pathology
College of American Pathologists
Massachusetts Medical Society
Nirmal AJ, Maliga Z, Vallius T, Quattrochi B, Chen AA, Jacobson CA, Pelletier RJ, Yapp C, Arias-Camison R, Chen YA, Lian CG, Murphy GF, Santagata S, Sorger PK. “The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution.” Cancer Discovery. 2022.
Quattrochi B, Russell-Goldman E. “Utility of Insulinoma-Associated Protein 1 (INSM1) and Mucin 2 (MUC2) Immunohistochemistry in the Distinction of Endocrine Mucin-Producing Sweat Gland Carcinoma From Morphologic Mimics.” Am J Dermatopathol. 2021.
Buchbinder E, Weirather J, Manos M, Quattrochi B, Sholl L, Brennick R, Bowling P, Bailey N, Magarace L, Ott P, Haq R, Izar B, Giobbie-Hurder A, Hodi S. “Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade.” Cancer Med. 2021.
Quattrochi B, Gulvady A, Driscoll DR, Sano M, Klimstra DS, Turner CE, Lewis BC. “MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.” Oncotarget. 2017.
Driscoll D, Karim S, Sano M, Gay D, Jacob W, Yu J, Mizukami Y, Gopinathan A, Jodrell D, Evans TR, Bardeesy N, Hall M, Quattrochi B, Klimstra D, Barry S, Sansom O, Lewis BC, Morton J. “mTORC2 signaling drives the development and progression of pancreatic cancer.” Cancer Res. 2016.
Sano M, Driscoll D, DeJesus-Monge WE, Quattrochi B, Appleman VA, Ou J, Zhu LJ, Yoshida N, Yamazaki S, Takayama T, Sugitani M, Nemoto N, Klimstra D, Lewis BC. “Activation of WNT/β-catenin signaling enhances pancreatic cancer development and the malignant potential via up-regulation of Cyr61/CCN1.” Neoplasia. 2016.
Quattrochi B, “Subtle Controllers: MicroRNAs Drive Pancreatic Tumorigenesis and Progression: A Dissertation” University of Massachusetts Medical School. GSBS Dissertations and Theses. 2015.
Sano M, Homma T, Hayashi E, Noda H, Amano Y, Tsujimura R, Yamada T, Quattrochi B, Nemoto N. “Clinicopathological characteristics of anaplastic carcinoma of the pancreas with rhabdoid features.” Virchows Archiv. 2014.
Pan D, Mao C, Quattrochi B, Friedline RH, Zhu LJ, Jung DY, Kim JK, Lewis B, Wang YX. “MicroRNA-378 controls classical brown fat expansion to counteract obesity.” Nat Commun. 2014.
Sigoillot FD, Lyman S, Huckins JF, Adamson B, Chung E, Quattrochi B, King RW. “A bioinformatics method identifies prominent off-targeted transcripts in RNAi screens.” Nat Methods. 2012.